Detalhe da pesquisa
1.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study.
Am J Hematol
; 95(7): 749-758, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233095
2.
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype.
Haematologica
; 104(6): 1168-1175, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523055
3.
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Ann Hematol
; 97(10): 1785-1795, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926156
4.
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
Blood
; 122(26): 4279-86, 2013 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144640
5.
Mixed T cell receptor dimers harbor potentially harmful neoreactivity.
Proc Natl Acad Sci U S A
; 107(24): 10972-7, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534461
6.
A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL.
Blood
; 116(26): 5930-40, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20844239
7.
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial.
Haematologica
; 102(2): e47-e51, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789677
8.
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.
Haematologica
; 95(6): 914-21, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20015886
9.
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.
Cancers (Basel)
; 12(11)2020 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33187229
10.
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Haematologica
; 93(6): 834-41, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18469352
11.
Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.
Exp Hematol
; 31(10): 881-9, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14550803
12.
Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.
Haematologica
; 88(8): 845-52, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12935972
13.
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
J Clin Oncol
; 32(3): 219-28, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297940
14.
Developing a European network for adult ALL.
Hematol J
; 5 Suppl 3: S46-52, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15190278
15.
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.
Blood
; 111(5): 2581-8, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172005
16.
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation.
Blood
; 102(4): 1548-9, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12900350